Maturation of adult peripheral blood CD38+CD4+ T cells demonstrated by cytokine production in response to a superantigen, TSST-1

Cellular Immunology

Volumn 222, Issue 2, 2003, Pages 89-96

  Imanishi, Ken'ichi ^a   Kato, Hidehito ^a   Fujii, Hisaichi ^a   Uchiyama, Takehiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Maturation; Superantigen; T cells; TSST 1

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 2; SUPERANTIGEN; TSST 1 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; CELL ACTIVATION; CELL ASSAY; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; INFECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0037783964     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00111-4     Document Type: Article

References (33)

1. + T cells. J. Immunol. 160:1998;112-119.
2. Takahashi N., Imanishi K., Nishida H., Uchiyama T. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J. Immunol. 155:1995;5213-5219.
3. Risdon G., Gaddy J., Horie M., Broxmeyer H.E. Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc. Natl. Acad. Sci. USA. 92:1995;2413-2417.
4. + T cells. Eur. J. Immunol. 28:1998;3057-3065.
5. Hassan J., Reen D.J. Human recent thymic emigrants - identification, expansion, and survival characteristics. J. Immunol. 167:2001;1970-1976.
6. Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet. 351:1998;1614-1619.
7. Takahashi N., Kato H., Imanishi K., Miwa K., Yamanami S., Nishida H., Uchiyama T. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J. Clin. Invest. 106:2000;1409-1415.
8. Alessio M., Roggero S., Funaro A., De Monte L.B., Peruzzi L., Geuna M., Malavasi F. CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. J. Immunol. 145:1990;878-884.
9. + lymphocytes. Role of the human CD38 molecule. J. Immunol. 153:1994;952-959.
10. Imanishi K., Inada K., Akatsuka H., Gu Y., Igarashi H., Uchiyama T. Tumor necrosis factor production by human T-cells stimulated with bacterial superantigens. Int. J. Immunopharmacol. 17:1995;841-848.
11. Funaro A., Spagnoli G.C., Ausiello C.M., Alessio M., Roggero S., Delia D., Zaccolo M., Malavasi F. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J. Immunol. 145:1990;2390-2396.
12. Cho Y.S., Han M.K., Choi Y.B., Yun Y., Shin J., Kim U.H. Direct interaction of the CD38 cytoplasmic tail and the Lck SH2 domain. Cd38 transduces T cell activation signals through associated Lck. J. Biol. Chem. 275:2000;1685-1690.
13. Malavasi F., Funaro A., Alessio M., DeMonte L.B., Ausiello C.M., Dianzani U., Lanza F., Magrini E., Momo M., Roggero S. CD38: a multi-lineage cell activation molecule with a split personality. Int. J. Clin. Lab. Res. 22:1992;73-80.
14. + lymphocytes. J. Immunol. 153:1994;952-958.
15. + glycohydrolase to a functional domain in the carboxyl terminus. J. Immunol. 158:1997;741-747.
16. + T cells. J. Biol. Chem. 276:2001;17455-17460.
17. Kato H., Takahashi N., Arimura Y., Imanishi K., Nishida H., Uchiyama T. The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase. J. Infect. Chemother. 8:2002;111-114.
18. Norrby-Teglund A., Lustig R., Kotb M. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates. Infect. Immun. 65:1997;5209-5215.
19. Akatsuka H., Imanishi K., Inada K., Yamashita H., Yoshida M., Uchiyama T. Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1. Clin. Exp. Immunol. 96:1994;422-426.
20. Andersson J., Nagy S., Bjork L., Abrams J., Holm S., Andersson U. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol. Rev. 127:1992;69-96.
21. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenary S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated lipopolysaccharide. J. Exp. Med. 197:2003;403-411.
22. Ismaili J., Rennesson J., Aksoy E., Vekemans J., Vincart B., Amraoui Z., Ven Laethem F., Goldman M., Dubois P.M. Monophosphoryl lipid A activates both human dendritic cells and T cells. J. Immunol. 168:2002;926-932.
23. Matsuguchi T., Tagkagi K., Musikacharoen T., Yoshikai Y. Gene expression of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood. 95:2000;1378-1385.
24. Deterre P., Gelman L., Gary-Gouy H., Arrieumerlou C., Berthelier V., Tixier J.M., Ktorza S., Goding J., Schmitt C., Bismuth G. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites. J. Immunol. 157:1996;1381-1388.
25. + T cells. Annu. Rev. Immunol. 12:1994;635-673.
26. + T cells, analyzed at the single-cell level. J. Exp. Med. 184:1996;473-483.
27. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:1997;297-322.
28. Nagata K., Tanaka K., Ogawa K., Kemmotsu K., Imai T., Yoshie O., Abe H., Tada K., Nakamura M., Sugamura K., Takano S. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162:1999;1278-1286.
29. Uchiyama T., Yan X.J., Imanishi K., Yagi J. Bacterial superantigens - mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol. Immunol. 38:1994;245-256.
30. Kotzin B.L., Leung D.Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 54:1993;99-166.
31. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 8:1995;411-426.
32. Norrby-Teglund A., Chatellier S., Low D.E., McGeer A., Green K., Kotb M. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur. J. Immunol. 30:2000;3247-3255.
33. Kotb M., Norrby-Teglund A., McGeer A., EL-Sherbini H., Dorak M.T., Khurshid A., Green K., Peeples J., Wade J., Thomson G., Schwarz B., Low D.E. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8:2002;1394-1404.